Janus Henderson Group PLC Eliem Therapeutics, Inc. Transaction History
Janus Henderson Group PLC
- $182 Billion
- Q2 2024
A detailed history of Janus Henderson Group PLC transactions in Eliem Therapeutics, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 3,253,988 shares of ELYM stock, worth $26 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,253,988Holding current value
$26 Million% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding ELYM
# of Institutions
46Shares Held
49.9MCall Options Held
0Put Options Held
0-
Ra Capital Management, L.P. Boston, MA31.4MShares$251 Million3.37% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.9MShares$31.2 Million0.91% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA3.26MShares$26 Million11.93% of portfolio
-
Boxer Capital, LLC San Diego, CA2.6MShares$20.8 Million1.03% of portfolio
-
Affinity Asset Advisors, LLC New York, NY1.67MShares$13.3 Million1.62% of portfolio
About Eliem Therapeutics, Inc.
- Ticker ELYM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,567,700
- Market Cap $212M
- Description
- Eliem Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in chronic pain, neuropsychiatry, epilepsy, and other disorders of the peripheral and central nervous systems. Its two lead drug candidates are ETX-810 for chronic pain, which is in Phase II...